Cart
sales@molnova.com
Benzetimide hydrochloride
CAS No. 5633-14-7
Benzetimide hydrochloride( R4929 )
Catalog No. M20827 CAS No. 5633-14-7
Benzetimide hydrochloride is an antagonist of muscarinic acetylcholine receptor.treatment neuroleptic-induced parkinsonism.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 42 | Get Quote |
|
| 25MG | 66 | Get Quote |
|
| 50MG | 87 | Get Quote |
|
| 100MG | 118 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBenzetimide hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzetimide hydrochloride is an antagonist of muscarinic acetylcholine receptor.treatment neuroleptic-induced parkinsonism.?
-
DescriptionBenzetimide hydrochloride is an antagonist of muscarinic acetylcholine receptor.treatment neuroleptic-induced parkinsonism.?
-
In Vitro——
-
In Vivo——
-
SynonymsR4929
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5633-14-7
-
Formula Weight398.93
-
Molecular FormulaC23H27ClN2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:32 mg/mL (80.21 mM)
-
SMILESCl.O=C1CCC(c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Klaassen A B M Kuijpers W Scheres H M E et al. Cholinergic Receptors in the Upper Respiratory System of the Rat[J]. Archives of Otolaryngology - Head and Neck Surgery 1986 112(4):428-431.
molnova catalog
related products
-
Apilimod mesylate
Apilimod mesylate is a potent?IL-12/IL-23?inhibitor.
-
Gabapentin
Gabapentin (brand name Neurontin) is a medication originally developed for the treatment of epilepsy.
-
Catestatin
Non-competitive nicotinic cholinergic antagonist; selectively inhibits nicotinic-stimulated catecholamine secretion from chromaffin cells and noradrenergic neurons (IC50 ~ 200 nM). Blocks nicotinic-induced cationic signaling (IC50 ~ 200 - 250 nM) and inhibits nicotinic-agonist induced desensitization of catecholamine release. Also stimulates mast cell release of histamine via a separate mechanism.
